Home › Type 2 Diabetes › NCT05893927
Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
Evaluating the Clinical Impact of a PCP Developed Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Age ≥ 18 years * Diagnosis of Type 2 Diabetes with HA1c \>8.0 * Current patients of the Family Healthcare Center, Reading Hospital Tower health. Exclusion Criteria: * Identified special populations (pregnancy or individuals currently incarcerated) * Patients without access to their own smart phone * Any patient who is unable to provide their own informed consent to participate in the study
About the study
The goal of this clinical trial is to evaluate the use and effectiveness of a mobile web application (app) that is designed to educate and allow patients to manage diabetes and make sustainable lifestyle changes, and to study the impact of the app on clinical outcomes of diabetes (HA1C) and educational outcomes (Self-Efficacy for Diabetes Scale). The main question to answer is: Does the use of the Diabetes Application significantly affect clinical outcomes of diabetes and cardiometabolic risk factors (BMI and Blood Pressure)? Patients will be enrolled in one of two available arms of the study.
Participants in the 'intervention arm' will use the app to view educational information presented as videos in the following areas: Healthy Coping, Healthy Eating, Staying Active, Medications (Use and Safety), Problem Solving in Diabetes and Disease Pathophysiology. They will continue routine follow-up care with their primary care physicians during the study.
Participants in the 'control arm' will continue with their primary care physician in routine follow-up care, as normally scheduled.
Researchers will compare the intervention arm participants to the control arm participants to find out about and compare changes in HA1C, systolic blood pressure, diastolic blood pressure, and body mass index. Groups will also be compared on the basis of self-perceived confidence of managing their diabetes by way of the Diabetes Self Efficacy Scale.
What is being tested
- Diabetes education web site application (other)
Sponsor: The Reading Hospital and Medical Center · Participants: 65 · Started: Feb 15, 2024
Contact the study team
- Mary E Alderfer, MSN · Phone: 484-628-8360
- Pamela Marrero · Phone: 484-628-8355
Official record on ClinicalTrials.gov — NCT05893927
Locations in the U.S.
| Pennsylvania | Reading Hospital, an affiliate of Tower Health, West Reading |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.